UnitedHealth Group (NYSE: UNH) recently reported its Q3 results, with revenues and earnings exceeding our expectations.
UnitedHealth earnings topped forecasts, but the Dow Jones member lowered the top end of its full-year outlook.
Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on UnitedHealth (UNH – Research Report) today and set a price target of ...
We recently compiled a list of the Jim Cramer is Talking About These 14 Stocks Before Earnings. In this article, we are going ...
Shares of UnitedHealth Group tumbled Tuesday as the company lowered its full-year outlook to reflect the impact of a February ...
Mizuho Securities analyst Ann Hynes has assigned their bullish stance on UNH stock, giving a Buy rating today. Ann Hynes has given her Buy ...
We recently compiled a list of 10 Safe Stocks To Invest In For The Long Term in 2024. In this article, we will look at where ...
Quarterly profit of $6.06 billion at the Minnetonka-based company beat analyst estimates on a per-share basis as revenue grew ...
The UNH stock performance is affected by management’s full-year 2024 outlook of $15.50 to $15.75 per share in net income, ...
What Are The Key Trends To Drive UnitedHealth’s Q3 Results? UnitedHealth should continue to benefit from an increase in total ...
On Tuesday, UnitedHealth Group (NYSE:UNH) reported better-than-expected third-quarter 2024 earnings but lowered the upper end ...